Literature DB >> 2167791

Effect of atrial natriuretic factor on bronchomotor tone in the normal human airway.

G Hulks1, A G Jardine, J M Connell, N C Thomson.   

Abstract

1. Asthmatic patients bronchodilate in response to infused atrial natriuretic factor. We wished to determine whether the airways of normal subjects responded in a similar way. 2. Changes in airway resistance, as determined by specific airway conductance, were measured in eight normal subjects in response to intravenous infusion of atrial natriuretic factor at doses of 0.5, 2 and 10 pmol min-1 kg-1. 3. No significant effect was observed on specific airway conductance at any rate of infusion despite maximum mean (SEM) plasma levels of 597 (62) pg of atrial natriuretic factor/ml in peripheral venous blood. 4. A second study was performed using six of the eight original subjects and employing a pharmacological dose of 50 pmol of atrial natriuretic factor min-1 kg-1. This produced mean plasma levels of 2056 pg/ml and a mean increase of 31% in specific airway conductance. 5. It is concluded that pharmacological, but not pathophysiological, elevations of plasma atrial natriuretic factor may significantly alter bronchomotor tone in normal subjects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167791     DOI: 10.1042/cs0790051

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  8 in total

1.  Humoral control of airway tone.

Authors:  N C Thomson; K D Dagg; S G Ramsay
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

2.  Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi.

Authors:  Maria G Matera; Luigino Calzetta; Daniela Passeri; Francesco Facciolo; Erino A Rendina; Clive Page; Mario Cazzola; Augusto Orlandi
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

3.  Comparative effects of activation of soluble and particulate guanylyl cyclase on cyclic GMP elevation and relaxation of bovine tracheal smooth muscle.

Authors:  S C Ijioma; R A Challiss; J P Boyle
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

4.  Bronchodilator and pre-protective effects of urodilatin in bovine bronchi in vitro: comparison with atrial natriuretic peptide.

Authors:  J E Nally; C C Docherty; R A Clayton; N C Thomson
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

5.  Circulating plasma concentrations of atrial natriuretic peptide and catecholamines in response to maximal exercise in normal and asthmatic subjects.

Authors:  G Hulks; A F Mohammed; A G Jardine; J M Connell; N C Thomson
Journal:  Thorax       Date:  1991-11       Impact factor: 9.139

Review 6.  Bronchodilation and bronchoprotection by deep inspiration and their relationship to bronchial hyperresponsiveness.

Authors:  Gwen Skloot; Alkis Togias
Journal:  Clin Rev Allergy Immunol       Date:  2003-02       Impact factor: 10.817

7.  Influence of atrial natriuretic peptide, brain natriuretic peptide and urodilatin on the histamine-induced bronchoconstriction in the conscious guinea pig.

Authors:  M Hermel
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 5.093

8.  Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis.

Authors:  R S Baliga; C J Scotton; S L Trinder; R C Chambers; R J MacAllister; A J Hobbs
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.